ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION AND CHRONIC ISCHEMIC HEART DISEASE

被引：1
|
作者：
Rychkov, A. Yu [1 ]
Khorkova, N. Yu [1 ]
机构：
[1] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, Russia
来源：
KARDIOLOGIYA | 2019年 / 59卷 / 05期
关键词：
atrial fibrillation; ischemic heart disease; oral anticoagulants; PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; VITAMIN-K ANTAGONIST; ORAL ANTICOAGULATION; ARTERY-DISEASE; ESC GUIDELINES; VS; PLACEBO; OPEN-LABEL; ASPIRIN; WARFARIN;
D O I：
10.18087/cardio.2019.5.n493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The review is devoted to the use of antithrombotic therapy in patients with atrial fibrillation (AF) and chronic ischemic heart disease (IHD). We discuss data of international registries, meta-analyses assessing possibilities of the use of oral anticoagulants for secondary prevention of IHD. We present here results of randomized and observational clinical studies demonstrating advantages of prescription of monotherapy with oral anticoagulants (OAC) in combination of AF and chronic IHD. Modern evidence base of advantages of dual antithrombotic therapy with the use of direct OAC following percutaneous coronary intervention is also presented.
引用
收藏
页码：80 / 86
页数：7
相关论文
共 50 条
  • [31] Antithrombotic therapy for atrial fibrillation in patients with acute ischemic stroke or transient ischemic attack
    Yeh, Poh-Shiow
    Yang, Chun-Ming
    Lin, Sheng-Hsiang
    Wang, Wei-Ming
    Chen, Po-Sheng
    Lin, Huey-Juan
    Lin, Kao-Chang
    Chang, Chia-Yu
    Cheng, Tain-Junn
    Li, Yi-Heng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 179 : 288 - 291
  • [32] TACTICS OF SELECTION OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE
    Belenkov, Yu. N.
    Shakaryants, G. A.
    Khabarova, N., V
    KARDIOLOGIYA, 2018, 58 (03) : 43 - 52
  • [33] Anticoagulant therapy for chronic heart disease atrial failure and fibrillation: A review
    Serova, Maria V.
    Sazonova, Yulia S.
    Derevinskaiia, Anastasiia S.
    Steklov, Alexander S.
    Andreev, Denis A.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (11) : 1083 - 1088
  • [34] Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis
    Zhu, Wengen
    Guo, Linjuan
    Liu, Fadi
    Wan, Rong
    Shen, Yang
    Lip, Gregory Y. H.
    Hong, Kui
    ONCOTARGET, 2017, 8 (46) : 81154 - 81166
  • [35] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Lili Wei
    Enyong Su
    Weili Liu
    Wenlu Xing
    Xinyun Liu
    You Zhang
    Shan Wang
    Qianqian Cheng
    Datun Qi
    Chuanyu Gao
    BMC Cardiovascular Disorders, 20
  • [36] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Wei, Lili
    Su, Enyong
    Liu, Weili
    Xing, Wenlu
    Liu, Xinyun
    Zhang, You
    Wang, Shan
    Cheng, Qianqian
    Qi, Datun
    Gao, Chuanyu
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [37] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease REPLY
    Yasuda, Satoshi
    Ogawa, Hisao
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2481 - 2481
  • [38] The future of antithrombotic and antiplatelet therapy for ischemic heart disease
    Topol, EJ
    AMERICAN HEART JOURNAL, 1998, 136 (04) : S66 - S68
  • [39] Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves
    Eikelboom, John W.
    Hart, Robert G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S100 - S107
  • [40] Clopidogrel as antithrombotic therapy in atrial fibrillation
    Veloso, HH
    de Paola, AAV
    CHEST, 2005, 128 (01) : 475 - 475
12345